Myocardial functional recovery following durable ventricular assist device in children

Background: Ventricular assist device (VAD) explantation following myocardial functional recovery (MFR) for heart failure (HF) is uncommon in children and is associated with a risk of HF recurrence. Material and Methods: Retrospective, single-center study of pediatric patients who were supported wit...

Full description

Saved in:
Bibliographic Details
Main Authors: Bhavikkumar Langanecha, Osami Honjo, Alyssa Power, Oshri Zaulan, Christoph Haller, Kristen George, Linda Fazari, Andrea Maurich, David Chiasson, Aamir Jeewa
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:JHLT Open
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2950133424001307
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823864246008545280
author Bhavikkumar Langanecha
Osami Honjo
Alyssa Power
Oshri Zaulan
Christoph Haller
Kristen George
Linda Fazari
Andrea Maurich
David Chiasson
Aamir Jeewa
author_facet Bhavikkumar Langanecha
Osami Honjo
Alyssa Power
Oshri Zaulan
Christoph Haller
Kristen George
Linda Fazari
Andrea Maurich
David Chiasson
Aamir Jeewa
author_sort Bhavikkumar Langanecha
collection DOAJ
description Background: Ventricular assist device (VAD) explantation following myocardial functional recovery (MFR) for heart failure (HF) is uncommon in children and is associated with a risk of HF recurrence. Material and Methods: Retrospective, single-center study of pediatric patients who were supported with durable VADs, both intracorporeal continuous flow devices (CFD) and paracorporeal pulsatile flow devices (PFD), between 2004 and 2022. Results: A total of 74 children, of which 43 were female, underwent VAD implantation (PFD = 61 and CFD = 14) at a median (interquartile range) age of 5.6 (0.8, 13.5) years and with a weight of 16.2 (7.5, 40.7) kg. From this cohort, we identified 9 of 75 (12%) children who underwent VAD explantation for MFR. Of those, 7 of 9 (77%) were under 2 years of age and 6 of 9 (67%) were supported for >90 days. Five patients had dilated cardiomyopathy, 3 with anomalous left coronary artery from pulmonary artery and 1 with tachycardia-induced cardiomyopathy. Six were listed for transplantation as a part of their HF management strategy following VAD implantation. After explant, 8 of 9 patients remained in HF remission with no symptoms and stable left ventricular function. One patient had a recurrence of HF following explantation after demonstrating MFR while on VAD support. Conclusions: MFR resulting in VAD explantation is feasible in children with chronic HF especially for those <2 years of age. Further work is needed to better identify the features that promote MFR and maintain it after explant.
format Article
id doaj-art-717f396ab4654a62a0cb5bd42d49f163
institution Kabale University
issn 2950-1334
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series JHLT Open
spelling doaj-art-717f396ab4654a62a0cb5bd42d49f1632025-02-09T05:01:56ZengElsevierJHLT Open2950-13342025-02-017100181Myocardial functional recovery following durable ventricular assist device in childrenBhavikkumar Langanecha0Osami Honjo1Alyssa Power2Oshri Zaulan3Christoph Haller4Kristen George5Linda Fazari6Andrea Maurich7David Chiasson8Aamir Jeewa9Labatt Family Heart Centre, Division of Pediatric Cardiology, Department of Pediatrics, University of Toronto, Hospital for Sick Children, Toronto, Ontario, Canada; Division of Critical Care Medicine, Department of Pediatrics, University of Toronto, Hospital for Sick Children, Toronto, Ontario, CanadaLabatt Family Heart Centre, Division of Cardiovascular Surgery, Department of Surgery, University of Toronto, The Hospital for Sick Children, Toronto, Ontario, CanadaLabatt Family Heart Centre, Division of Pediatric Cardiology, Department of Pediatrics, University of Toronto, Hospital for Sick Children, Toronto, Ontario, CanadaLabatt Family Heart Centre, Division of Pediatric Cardiology, Department of Pediatrics, University of Toronto, Hospital for Sick Children, Toronto, Ontario, Canada; Division of Critical Care Medicine, Department of Pediatrics, University of Toronto, Hospital for Sick Children, Toronto, Ontario, CanadaLabatt Family Heart Centre, Division of Cardiovascular Surgery, Department of Surgery, University of Toronto, The Hospital for Sick Children, Toronto, Ontario, CanadaLabatt Family Heart Centre, Division of Pediatric Cardiology, Department of Pediatrics, University of Toronto, Hospital for Sick Children, Toronto, Ontario, CanadaLabatt Family Heart Centre, Division of Pediatric Cardiology, Department of Pediatrics, University of Toronto, Hospital for Sick Children, Toronto, Ontario, CanadaLabatt Family Heart Centre, Division of Pediatric Cardiology, Department of Pediatrics, University of Toronto, Hospital for Sick Children, Toronto, Ontario, CanadaDepartment of Laboratory Medicine &amp; Pathobiology, University of Toronto, Hospital for Sick Children, Toronto, Ontario, CanadaLabatt Family Heart Centre, Division of Pediatric Cardiology, Department of Pediatrics, University of Toronto, Hospital for Sick Children, Toronto, Ontario, Canada; Corresponding author: Aamir Jeewa, Labatt Family Heart Centre, Division of Pediatric Cardiology, The Hospital for Sick Children, 555 University Avenue, Toronto, ON M5G 1x8, Canada.Background: Ventricular assist device (VAD) explantation following myocardial functional recovery (MFR) for heart failure (HF) is uncommon in children and is associated with a risk of HF recurrence. Material and Methods: Retrospective, single-center study of pediatric patients who were supported with durable VADs, both intracorporeal continuous flow devices (CFD) and paracorporeal pulsatile flow devices (PFD), between 2004 and 2022. Results: A total of 74 children, of which 43 were female, underwent VAD implantation (PFD = 61 and CFD = 14) at a median (interquartile range) age of 5.6 (0.8, 13.5) years and with a weight of 16.2 (7.5, 40.7) kg. From this cohort, we identified 9 of 75 (12%) children who underwent VAD explantation for MFR. Of those, 7 of 9 (77%) were under 2 years of age and 6 of 9 (67%) were supported for >90 days. Five patients had dilated cardiomyopathy, 3 with anomalous left coronary artery from pulmonary artery and 1 with tachycardia-induced cardiomyopathy. Six were listed for transplantation as a part of their HF management strategy following VAD implantation. After explant, 8 of 9 patients remained in HF remission with no symptoms and stable left ventricular function. One patient had a recurrence of HF following explantation after demonstrating MFR while on VAD support. Conclusions: MFR resulting in VAD explantation is feasible in children with chronic HF especially for those <2 years of age. Further work is needed to better identify the features that promote MFR and maintain it after explant.http://www.sciencedirect.com/science/article/pii/S2950133424001307left ventricular assist device (LVAD)myocardial functional recoveryventricular assist device explantheart failureheart transplantreverse remodeling
spellingShingle Bhavikkumar Langanecha
Osami Honjo
Alyssa Power
Oshri Zaulan
Christoph Haller
Kristen George
Linda Fazari
Andrea Maurich
David Chiasson
Aamir Jeewa
Myocardial functional recovery following durable ventricular assist device in children
JHLT Open
left ventricular assist device (LVAD)
myocardial functional recovery
ventricular assist device explant
heart failure
heart transplant
reverse remodeling
title Myocardial functional recovery following durable ventricular assist device in children
title_full Myocardial functional recovery following durable ventricular assist device in children
title_fullStr Myocardial functional recovery following durable ventricular assist device in children
title_full_unstemmed Myocardial functional recovery following durable ventricular assist device in children
title_short Myocardial functional recovery following durable ventricular assist device in children
title_sort myocardial functional recovery following durable ventricular assist device in children
topic left ventricular assist device (LVAD)
myocardial functional recovery
ventricular assist device explant
heart failure
heart transplant
reverse remodeling
url http://www.sciencedirect.com/science/article/pii/S2950133424001307
work_keys_str_mv AT bhavikkumarlanganecha myocardialfunctionalrecoveryfollowingdurableventricularassistdeviceinchildren
AT osamihonjo myocardialfunctionalrecoveryfollowingdurableventricularassistdeviceinchildren
AT alyssapower myocardialfunctionalrecoveryfollowingdurableventricularassistdeviceinchildren
AT oshrizaulan myocardialfunctionalrecoveryfollowingdurableventricularassistdeviceinchildren
AT christophhaller myocardialfunctionalrecoveryfollowingdurableventricularassistdeviceinchildren
AT kristengeorge myocardialfunctionalrecoveryfollowingdurableventricularassistdeviceinchildren
AT lindafazari myocardialfunctionalrecoveryfollowingdurableventricularassistdeviceinchildren
AT andreamaurich myocardialfunctionalrecoveryfollowingdurableventricularassistdeviceinchildren
AT davidchiasson myocardialfunctionalrecoveryfollowingdurableventricularassistdeviceinchildren
AT aamirjeewa myocardialfunctionalrecoveryfollowingdurableventricularassistdeviceinchildren